ImmunoPrecise Antibodies (IPA) News Today $0.43 +0.03 (+7.56%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$0.41 -0.02 (-4.71%) As of 04/11/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing MethodsApril 11 at 11:42 AM | uk.finance.yahoo.comImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing MethodsApril 11 at 8:54 AM | financialpost.comImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody DiscoveryApril 10 at 6:54 AM | tipranks.comHC Wainwright Has Bullish Outlook for IPA FY2025 EarningsApril 4, 2025 | americanbankingnews.comBenchmark Reaffirms "Speculative Buy" Rating for ImmunoPrecise Antibodies (NASDAQ:IPA)April 3, 2025 | americanbankingnews.comHC Wainwright Has Bearish Outlook for IPA FY2028 EarningsApril 3, 2025 | americanbankingnews.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call TranscriptApril 1, 2025 | msn.comImmunoPrecise Antibodies reports Q3 EPS (C$0.66) vs. (C$0.10) last yearMarch 29, 2025 | markets.businessinsider.comIMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and MoreMarch 28, 2025 | nasdaq.comImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call TranscriptMarch 28, 2025 | seekingalpha.comImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025March 28, 2025 | businesswire.comImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.March 13, 2025 | financialpost.comImmunoPrecise Antibodies Reschedules Q3 Financial Results ReleaseMarch 11, 2025 | tipranks.comIPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025March 11, 2025 | financialpost.comIPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025March 11, 2025 | businesswire.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025March 5, 2025 | financialpost.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025March 5, 2025 | businesswire.comImmunoPrecise Antibodies Ltd. (IPA) Expands AI Leadership with Dr. Kamil Isaev AppointmentFebruary 27, 2025 | insidermonkey.comImmunoPrecise Antibodies announces strategic collaboration with RiboproFebruary 26, 2025 | markets.businessinsider.comImmunoPrecise Antibodies and RIBOPRO Partner to Revolutionize Antibody DiscoveryFebruary 26, 2025 | tipranks.comIPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in ImmunotherapyFebruary 26, 2025 | businesswire.comImmunoPrecise Antibodies Transfers to Nasdaq Capital Market, Gains ExtensionFebruary 20, 2025 | tipranks.comImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance PeriodFebruary 20, 2025 | businesswire.comImmunoPrecise Antibodies Boosts Financial Position Through Successful Capital InitiativesFebruary 3, 2025 | tipranks.comTop 10 AI Stocks Dominating Wall StreetJanuary 27, 2025 | msn.comImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech InnovationJanuary 27, 2025 | msn.comImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville DebentureJanuary 27, 2025 | businesswire.comThis Biotech Soared On Wednesday Following AI-Related AnnouncementJanuary 22, 2025 | msn.comIPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes TreatmentJanuary 22, 2025 | businesswire.comImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ PlatformJanuary 20, 2025 | insidermonkey.comImmunoPrecise Antibodies Launches AI-Powered Drug Discovery PlatformJanuary 17, 2025 | tipranks.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | financialpost.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | financialpost.comImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationJanuary 17, 2025 | businesswire.comImmunoPrecise Antibodies finance chief to step downJanuary 2, 2025 | msn.comImmunoPrecise Antibodies CFO Kristin Taylor To ResignJanuary 1, 2025 | markets.businessinsider.comImmunoPrecise Antibodies announces resignation of CFOJanuary 1, 2025 | markets.businessinsider.comImmunoPrecise Antibodies CFO Resignation and SuccessionDecember 31, 2024 | tipranks.comIPA Announces Resignation of Chief Financial OfficerDecember 31, 2024 | businesswire.com$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property AdvisorsDecember 30, 2024 | businesswire.comImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share PurchasesDecember 23, 2024 | businesswire.comImmunoPrecise Antibodies to Showcase at Microcap ConferenceDecember 19, 2024 | tipranks.comImmunoPrecise Antibodies Reports Q2 Results and Strategic Advances in AI-Driven Drug DiscoveryDecember 11, 2024 | markets.businessinsider.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call TranscriptDecember 11, 2024 | msn.comImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call TranscriptDecember 10, 2024 | seekingalpha.comImmunoPrecise Antibodies Ltd.December 5, 2024 | thestreet.comImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationNovember 4, 2024 | businesswire.comImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyOctober 28, 2024 | businesswire.comInstitutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts DistrictOctober 16, 2024 | businesswire.comImmunoPrecise Antibodies earnings preview: what Wall Street is expectingSeptember 15, 2024 | markets.businessinsider.com Remove Ads Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address IPA Media Mentions By Week IPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.650.95▲Average Medical News Sentiment IPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼51▲IPA Articles Average Week Remove Ads Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PMV Pharmaceuticals News Ikena Oncology News vTv Therapeutics News Immuneering News ImmuCell News VolitionRx News Applied Therapeutics News Kronos Bio News bluebird bio News BeyondSpring News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IPA Stock Free IPA Stock Alerts